Tocilizumab administration in a refractory case of COVID-19.

Dastan, Farzaneh; Nadji, Seyed Alireza; Saffaei, Ali; Tabarsi, Payam

Dastan, Farzaneh; Nadji, Seyed Alireza; Saffaei, Ali; Tabarsi, Payam.

Dastan F; Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Ira
Nadji SA; Virology Research Center, National Institutes of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: sarnadji@yahoo.com.
Saffaei A; Student Research Committee, Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: alisaffaei.ss@gmail.com.
Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: payamtabarsi@yahoo.com.

Int J Antimicrob Agents ; 56(2): 106043, 2020 Aug.

Article in English | MEDLINE | ID: covidwho-459016

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Betacoronavirus/isolation & purification; Coronavirus Infections/complications; Coronavirus Infections/drug therapy; Cytokine Release Syndrome/drug therapy; Immunologic Factors/administration & dosage; Pneumonia, Viral/complications; Pneumonia, Viral/drug therapy; Adult; COVID-19; Coronavirus Infections/pathology; Humans; Lung/diagnostic imaging; Lung/pathology; Male; Pandemics; Pneumonia, Viral/pathology; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus / Cytokine Release Syndrome / Immunologic Factors Type of study: Case report / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article Affiliation country: J.ijantimicag.2020.106043

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google